Aurobindo Pharma consolidated net profit declines 1.67% in the June 2021 quarter

Sales decline 2.46% to Rs 5691.85 crore

Net profit of Aurobindo Pharma declined 1.67% to Rs 769.97 crore in the quarter ended June 2021 as against Rs 783.06 crore during the previous quarter ended June 2020. Sales declined 2.46% to Rs 5691.85 crore in the quarter ended June 2021 as against Rs 5835.23 crore during the previous quarter ended June 2020. ParticularsQuarter EndedJun. 2021Jun. 2020% Var.Sales5691.855835.23 -2 OPM %21.0921.34 -PBDT1297.401339.87 -3 PBT1017.711084.35 -6 NP769.97783.06 -2

Powered by Capital Market - Live News